GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
I

Immunovia AB (publ) IMMNOV.ST · SEK

Health Care · Nasdaq Stockholm · 🇸🇪 Sweden

Compare

0.03

-10.43%

Close of 9 Nov 2026, in SEK

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

Immunovia AB (publ) annual report

Figures from our data supplier

We don't hold this company's report document. It publishes it on its own website.

Company website ↗

Five-year highlights

In SEK.

FY2025FY2024FY2023FY2022FY2021
RevenueSEK 685,000SEK 931,000SEK 1.6mSEK 1.1mSEK 844,000
Operating income−SEK 79.5m−SEK 109.4m−SEK 281.9m−SEK 191.2m−SEK 166.7m
Net income−SEK 145.9m−SEK 76.5m−SEK 309.4m−SEK 145.0m−SEK 157.4m
Free cash flow−SEK 84.0m−SEK 96.8m−SEK 148.1m−SEK 177.2m−SEK 176.8m
Total assetsSEK 88.2mSEK 33.0mSEK 98.7mSEK 300.6mSEK 493.8m
Shareholders' equitySEK 64.7mSEK 11.6mSEK 67.0mSEK 243.8mSEK 433.9m

Sources and methodology

Data on this tab
SEC EDGAR and our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.